Healthcare -
Drug Manufacturers - General - NYSE - US
$ 26.3
-0.717 %
$ 149 B
Market Cap
35.07
P/E
PFE - COST OF REVENUE
Cost of Revenue PFE - Pfizer Inc.
29.7 B
LAST VALUE
-1.86%
2 YEAR CAGR
21.42%
5 YEAR CAGR
11.97%
10 YEAR CAGR